Secondaries Announced 10.11.17

IPO BOUTIQUE CLIENTS and IPO BOUTIQUE SECONDARY ALERTS CLIENTS received ALL this information to their inbox on a REAL TIME basis.

If having real-time alerts for secondary offerings would be an advantage to you, inquire about a subscription today!

Our Buy, Neutral or Avoid ratings of the Secondaries below are intended as a recommendation for those who buy Secondaries on a regular basis. For example, this is not to be interpreted as a Buy recommendation in the traditional sense of adding to your stock portfolio; this is a short term (usually one day or opening trade) time period.

Company:  Protagonist Therapeutics, Inc.
Symbol:     PTGX
Price:       Last Trade $19.81
Trade Date:    10/12
Shares: 2.9 million ($50m cash raise)
Re-Offer Range: Subscription Needed
Underwriter(s)    : Leerink, Barclays, BMO Capital Markets, Stifel
Co-Manager(s): BTIG, Nomura
Description:  Protagonist is a clinical development-stage biopharmaceutical company that utilizes a proprietary technology platform to discover and develop novel peptide-based drugs to address significant unmet medical needs.
Rating = Subscription Needed